Written and maintained by CASRAI Editorial Board
Published
On this page
General information only, not medical advice. Catheter choice, placement and removal are decisions and procedures for treating clinicians.
Short answer
“Vascath” is everyday shorthand for a non-tunneled (non-cuffed) central venous catheter used for temporary dialysis access, typically in the neck or groin. The word began as a brand name and now works as a generic term. Under US regulation, a catheter intended for under 30 days is “nonimplanted”; guideline advice is to keep non-cuffed dialysis catheters to about two weeks.
Definition and scope
In clinical conversation, a vascath is a large-bore, usually double-lumen catheter placed in a central vein so that blood can be drawn out and returned during hemodialysis. It is a short-term device. “Vascath” is a brand-origin term (Vas-Cath is a Bard Access Systems brand name), so staff may use it for any equivalent temporary dialysis catheter whatever the manufacturer. Product records and orders should use the device’s actual labeled name rather than the shorthand.
It overlaps with, but is narrower than, a central venous catheter. Many central lines carry fluids and drugs; a vascath is specifically sized and labeled for dialysis blood flow. A longer-term alternative is the cuffed, tunneled catheter described in What Is a Hemodialysis Catheter?.
How it is used in practice
Named sources frame the use case consistently:
- Duration. The KDOQI 2019 vascular access guideline says a nontunneled internal jugular catheter should be used only for temporary purposes and a limited time, and that non-cuffed nontunneled dialysis catheters be limited to a maximum of about two weeks for patients who need emergent access (graded expert opinion).
- Preference when longer access is needed. The same guideline considers a tunneled catheter reasonable in preference to a nontunneled one because of its lower infection risk. Tunneled cuffed catheters have no fixed maximum duration but need regular evaluation.
- Site. For prolonged central venous catheter use the guideline lists internal jugular, external jugular, femoral, subclavian and lumbar sites, with the right side preferred for its more direct anatomy. A femoral tunneled cuffed catheter is accepted by some experts for limited use (for example under a month) in urgent-start patients, and it preserves upper-extremity veins for later fistula or graft access. Femoral or iliac vessel disease is a contraindication.
- Who places and removes it. Insertion and removal are performed by trained clinicians under facility protocols. This page deliberately gives no procedural steps.
Infection is the main safety concern with any central line; surveillance definitions are covered in CLABSI: NHSN surveillance definition.
Types and related concepts: a sourced comparison
| Term | What the sources say | Source |
|---|---|---|
| Vascath (non-tunneled, non-cuffed dialysis catheter) | Temporary; emergent access; about two weeks maximum per KDOQI | KDOQI 2019 |
| Tunneled cuffed catheter | No maximum duration, regular evaluation required; preferred over nontunneled for lower infection risk | KDOQI 2019 |
| Regulatory class: nonimplanted blood access device | Tubes such as catheters, cannulae or hollow needles intended for under 30 days; Class II | 21 CFR 876.5540 |
| Regulatory class: implanted blood access device | Surgically implanted for 30 days or more; Class II with special controls | 21 CFR 876.5540 |
The regulatory split (30 days) and the clinical guideline limit (about two weeks) measure different things: the first is the manufacturer’s intended-use category, the second is clinical practice advice. A vascath fits the nonimplanted category; a cuffed tunneled catheter intended for long-term use falls on the implanted side.
Where it matters for labs, clinics and supply decisions
Staff who stock or reconcile dialysis catheters can use this checklist of facts that the device’s own labeling and public registries record. It is a record-matching aid, not a selection guide:
- The labeled device name and manufacturer, not the shorthand “vascath”. NLM’s AccessGUDID shows a brand name and GMDN term for each registered device.
- Lumen count and the intended connection to dialysis lines; see catheter lumen.
- French size and length as stated in the instructions for use.
- Intended duration of use as labeled, which determines whether the product is treated as nonimplanted or implanted under 21 CFR 876.5540.
- Accessories such as dialysis clamps and the facility’s own line-care protocol.
Common misunderstandings
- “A vascath is a brand-neutral product category.” It started as one brand’s name; equivalent catheters from other makers are also called vascaths in practice.
- “Any central line can be used for dialysis.” Dialysis access depends on the device’s labeled intended use; many central lines are not labeled for it.
- “Femoral and jugular vascaths are the same.” The KDOQI guideline treats site as a separate decision, with femoral use described as limited. See also the internal jugular catheter guide.
- “Temporary means no maintenance.” Non-cuffed catheters carry infection risk, which is why guidelines limit their duration.
FAQ
What is a vascath?
A temporary, non-tunneled central venous catheter used for hemodialysis access. The name derives from the Vas-Cath brand.
How is a vascath different from a CVC?
A vascath is a type of central venous catheter specifically for dialysis blood flow; a general CVC may be intended for infusions or monitoring.
How long can a vascath stay in?
KDOQI 2019 advises about two weeks maximum for non-cuffed nontunneled dialysis catheters. The individual’s duration is a clinical decision.
Why is the femoral site discussed?
KDOQI lists the femoral vein among possible sites but describes femoral use as limited, and notes it preserves upper-extremity vessels for future fistula or graft access.
Is vascath insertion or removal covered here?
No. Both are clinician-performed procedures governed by facility protocols and the manufacturer’s instructions for use.
Sources
- US Code of Federal Regulations, 21 CFR 876.5540, Blood access device and accessories, read 2026-11-07.
- KDOQI Clinical Practice Guideline for Vascular Access, 2019 update, via Guideline Central summary, read 2026-11-07.
- National Library of Medicine, AccessGUDID, device record fields checked 2026-11-07.







